Babies can be born with liver problems for a surprisingly wide range of reasons, from structural defects in the bile ducts to inherited metabolic conditions, immune reactions between mother and fetus, and infections picked up in the womb. Some of these conditions announce themselves within the first days of life with obvious jaundice or feeding difficulty, while others lurk quietly for weeks before a routine blood test flags something off. The causes fall into several broad categories, and understanding them matters because early recognition often determines whether a baby’s liver can recover or whether more serious intervention is needed.
Biliary Atresia
Biliary atresia is one of the most common and serious liver conditions in newborns, and also one of the most puzzling. It occurs when the bile ducts inside or outside the liver become inflamed, scarred, and eventually blocked. Bile, which the liver produces to help digest fats and clear waste, has nowhere to go. It backs up into the liver, causing progressive damage. Babies with biliary atresia typically look healthy at birth but develop worsening jaundice, pale stools, and dark urine within the first few weeks of life.
Researchers still do not fully understand why biliary atresia happens, but the leading theory involves a chain reaction. Evidence suggests that a viral infection in early life triggers destruction of the cells lining the bile ducts. That initial injury releases cellular debris that provokes a strong immune response, which then causes further damage to the ducts and eventually obstructive scarring of the entire biliary system.1PubMed Central. Biliary atresia: pathology, etiology and pathogenesis In other words, the body’s own immune system may be doing much of the lasting harm after the initial insult.
Without treatment, biliary atresia is fatal. The standard first step is a surgery called the Kasai portoenterostomy, which reroutes bile flow by connecting a loop of intestine directly to the liver surface. Roughly 20 to 30 percent of babies who undergo this procedure will live jaundice-free into adulthood. Another third gain years of improved health but eventually need a liver transplant during childhood. The remaining 30 to 40 percent do not benefit enough from the surgery and face liver failure in infancy.2Hepatology. Sequential treatment of biliary atresia with kasai portoenterostomy and liver transplantation: A review This makes biliary atresia the single most common reason for pediatric liver transplant worldwide.
Choledochal Cysts
A choledochal cyst is an abnormal dilation of the bile ducts that forms before birth. These cysts can involve the ducts inside the liver, outside it, or both.3PubMed Central. A giant choledochal cyst in infancy: a case report They are considered uncommon overall but show up far more frequently in certain populations: the condition is much more common in East Asian females and tends to run in families.4PubMed. Choledochal cyst Two factors are thought to be responsible: a weakness in the bile duct wall and an obstruction downstream that causes pressure to build up, ballooning the duct into a cyst.5NATIONAL JOURNAL OF LABORATORY MEDICINE. Histopathological Changes of Liver Observed in Paediatric Patients Presenting with Choledochal Cyst
If left untreated, choledochal cysts can cause bile to stagnate, leading to liver inflammation, stone formation, and in rare cases malignant transformation later in life. Prenatal ultrasound can sometimes pick them up before birth, and postnatal ultrasound is the go-to tool for confirming the diagnosis and measuring the extent of duct dilation.3PubMed Central. A giant choledochal cyst in infancy: a case report Surgical removal of the cyst with reconstruction of the bile drainage system is typically curative.
Genetic Conditions That Affect Bile Flow
Several inherited conditions directly impair the liver’s ability to produce or transport bile, and they tend to show up early in life as persistent jaundice.
Alagille syndrome is one of the better-known examples. It is caused by mutations in genes involved in a developmental signaling pathway: most cases stem from a mutation in a gene called JAG1, though a small number involve a different gene called NOTCH2.6PubMed Central. Alagille syndrome: pathogenesis, diagnosis and management The result is that the liver develops with too few bile ducts inside it, a condition called bile duct paucity. Bile backs up, causing cholestasis (the medical term for impaired bile flow) and chronic jaundice. But Alagille syndrome is not just a liver disease. It can also affect the heart, spine, eyes, kidneys, and facial features.7PubMed. Alagille syndrome: an overview Severity varies enormously even within the same family, which is part of what makes it tricky to predict outcomes at birth.
Progressive familial intrahepatic cholestasis, or PFIC, is a group of rarer genetic conditions where the proteins that transport bile acids or related molecules across liver cell membranes are defective. Different types of PFIC are caused by defects in different transporter genes.8PubMed Central. A Comprehensive Review of Progressive Familial Intrahepatic Cholestasis (PFIC): Genetic Disorders of Hepatocanalicular Transporters Babies with PFIC develop severe itching and jaundice, and the condition tends to worsen over time, with some forms eventually requiring liver transplant.
Alpha-1-Antitrypsin Deficiency
Alpha-1-antitrypsin deficiency deserves its own mention because it is the most common genetic cause of liver disease in children and the most frequent inherited reason for pediatric liver transplant. It affects roughly one in 1,600 to one in 2,000 live births, especially among people of Northern European descent.9PubMed Central. Alpha-1-Antitrypsin Deficiency: An Important Cause of Pediatric Liver Disease
Alpha-1-antitrypsin is a protein made by the liver that normally protects the lungs from damage by immune-system enzymes. When the gene for this protein carries certain mutations, the liver produces a misfolded version that gets stuck inside liver cells instead of being released into the bloodstream. The trapped protein builds up and damages the liver from within. Lung problems from the deficiency rarely show up before the third decade of life, but liver disease can appear as early as one to two months of age. Around four to ten percent of affected children develop clinically significant liver disease during their first twenty years.9PubMed Central. Alpha-1-Antitrypsin Deficiency: An Important Cause of Pediatric Liver Disease The rest may carry the deficiency without obvious liver symptoms in childhood, though they remain at risk for problems later.
Metabolic Disorders
A number of inherited metabolic diseases can cause the liver to fail rapidly in newborns or young infants. These conditions involve missing or defective enzymes that leave the body unable to process certain sugars, amino acids, or fats. The toxic buildup of these substances hits the liver hard because the liver is the body’s primary metabolic processing center.
A study at a major pediatric referral center found that out of 127 children presenting with acute liver failure, about a quarter had an underlying metabolic cause. The most common was galactosemia, a condition where the body cannot break down the sugar galactose found in milk. Other metabolic causes included mitochondrial disorders, deficiencies in specific enzymes needed to process amino acids (such as ornithine transcarbamylase deficiency and tyrosinemia type 1), and rare storage diseases.10PubMed. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King’s College Hospital experience A separate study similarly found that more than half of its acute liver failure cases in young children traced back to inherited metabolic diseases, with galactosemia, mitochondrial DNA depletion syndromes, and urea cycle defects topping the list.11Anales de PediatrÃa (English Edition). Acute liver failure related to inherited metabolic diseases in young children
The clinical picture with metabolic liver failure can be dramatic. A baby who seemed fine at birth may develop poor feeding, vomiting, low blood sugar, and rapidly rising liver enzymes within days, particularly once regular milk feeding begins (in the case of galactosemia or hereditary fructose intolerance). Mitochondrial disorders can present with liver failure alongside low muscle tone or neurological problems, and mutations affecting mitochondrial DNA maintenance have been linked to conjugated jaundice, elevated liver enzymes, and progression to fatal liver failure in early infancy.12PubMed. Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion
Gestational Alloimmune Liver Disease
One of the more unusual causes of neonatal liver failure involves the mother’s immune system attacking the baby’s liver before birth. This condition, called gestational alloimmune liver disease (GALD), is the principal cause of what used to be known as neonatal hemochromatosis, a severe condition characterized by massive iron deposits in the liver and other organs.13PubMed. Gestational alloimmune liver disease and neonatal hemochromatosis
The mechanism is conceptually similar to how Rh disease affects red blood cells, but here the target is the fetal liver. During pregnancy, the mother becomes sensitized to a protein on the surface of fetal liver cells. Her immune system produces antibodies against that protein, which cross the placenta and attack the baby’s hepatocytes. The antibodies activate a cascade that destroys liver cells.14Paediatrica Indonesiana. Neonatal hemochromatosis attributed to gestational alloimmune liver disease treated with intravenous immunoglobulin and exchange transfusion therapy Babies can be born with severe liver damage and iron overload. GALD is rare, but the damage it causes is often severe, and it tends to recur in subsequent pregnancies if untreated. Fortunately, giving the mother intravenous immunoglobulin during pregnancy can significantly reduce the severity in future pregnancies by dampening the harmful antibody response.15PubMed Central. Gestational alloimmune liver disease reconsidered: Advocating for a new nomenclature and enhanced diagnosis accuracy
Infections Acquired Before or During Birth
Certain infections passed from mother to baby during pregnancy or delivery can damage the developing liver. Cytomegalovirus (CMV) is among the most common. It belongs to the herpes virus family and can cross the placenta during a maternal infection. The virus has a particular affinity for the liver, and congenital CMV infection can cause hepatitis, enlarged liver, abnormal liver enzymes, and jaundice in the newborn.16PubMed. Hepatic involvement in congenital cytomegalovirus infection – infrequent yet significant In one series, more than half of the affected infants had mothers who experienced their first CMV infection during pregnancy, which carries the highest risk of transmission.
Enteroviruses are another serious threat. Certain strains, particularly coxsackieviruses and echoviruses, can cause fulminant hepatitis in newborns, meaning rapid and overwhelming liver destruction. This is one of the most severe complications of neonatal enterovirus infection and can lead to disseminated intravascular coagulation, where the blood’s clotting system breaks down catastrophically.17PubMed Central. Therapeutics for fulminant hepatitis caused by enteroviruses in neonates Herpes simplex virus, rubella, and toxoplasmosis are other well-recognized infectious causes of liver injury in newborns, though their frequency has declined in countries with robust vaccination and prenatal screening programs.
Vascular Problems and Birth Complications
The liver has an enormous blood supply, and abnormalities in its blood vessels can cause trouble right from birth. Hepatic hemangiomas (benign tumors made of blood vessels) and arteriovenous malformations (abnormal connections between arteries and veins) can present in infancy with an enlarged liver, heart failure from the sheer volume of blood being shunted through the liver, and anemia.18PubMed. Hepatic vascular anomalies in infancy: a twenty-seven-year experience Some of these resolve on their own as the child grows; others require medication or intervention.
Perinatal asphyxia, which occurs when a baby does not get enough oxygen around the time of delivery, is another common cause of liver injury in the newborn period. Oxygen deprivation redirects blood flow away from the liver to protect the brain and heart, and the resulting lack of blood flow to the liver damages its cells. A study of asphyxiated newborns found that nearly half had impaired liver function in the first day of life, with liver enzyme levels rising in proportion to the severity of oxygen deprivation.19PubMed Central. Hepatic Injury in Neonates with Perinatal Asphyxia This type of liver injury is usually temporary and improves as the baby recovers from the asphyxia, but in severe cases it can contribute to multi-organ failure.
Maternal Health and Its Effects on the Fetal Liver
A mother’s own metabolic health during pregnancy can shape the baby’s liver even before birth. Conditions like gestational diabetes and obesity-related metabolic disease alter the environment the fetus develops in. When a mother has poorly controlled blood sugar, excess glucose crosses the placenta, causing the fetus to produce abnormally high levels of insulin. This combination of fetal hyperglycemia and hyperinsulinemia promotes excessive growth and fat accumulation in the fetal liver.20PubMed Central. Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update In effect, the baby can be born with a fatty liver, and the metabolic disruption may predispose the child to liver and metabolic problems for years to come.
Alcohol and certain drugs used during pregnancy can also harm the developing liver. Fetal alcohol spectrum disorders are well documented, and while the brain gets most of the attention, the liver is also vulnerable to alcohol-mediated damage during development. The picture with medications is more nuanced and mostly studied in animal models; for example, prenatal acetaminophen exposure in mice has been shown to reduce the number of blood-forming stem cells in the fetal liver, though direct extrapolation to human clinical risk is still uncertain.
How These Conditions Are Detected
One of the biggest challenges with neonatal liver disease is catching it early enough to intervene. Jaundice is extraordinarily common in healthy newborns, so the difficulty lies in distinguishing normal physiological jaundice (caused by the breakdown of fetal red blood cells) from pathological jaundice caused by liver or bile duct disease. The key difference is the type of bilirubin involved. Physiological jaundice involves unconjugated (indirect) bilirubin, while liver and biliary problems cause a rise in conjugated (direct) bilirubin.
Research into newborn screening for cholestatic liver disease has focused on measuring direct bilirubin levels in the blood samples already collected for standard metabolic screening. One study found that a direct bilirubin cutoff of 0.6 mg/dL picked up all cases of cholestatic liver disease with 99 percent specificity, but in practice only a quarter of babies who screened positive came back for follow-up testing, and just 5 percent were eventually diagnosed with liver disease.21PubMed Central. Evaluation of Newborn Direct Bilirubin As Screening for Cholestatic Liver Disease A larger pilot specifically targeting biliary atresia found that a two-stage screening approach (checking direct bilirubin at birth and again if elevated) caught all known cases in the study population.22JAMA. Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements The screening itself works well; the weak link is getting families back for confirmatory testing.
For genetic and metabolic conditions, expanded newborn screening panels are increasingly powerful. Programs that combine traditional biochemical testing of dried blood spots with genetic sequencing can now identify conditions like methylmalonic acidemia and Wilson’s disease in the newborn period.23PubMed Central. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates In one Italian program, pairing biochemical screening with gene sequencing of over 100 disease-related genes solved every case, and in about 38 percent of cases the combination of both methods was essential for reaching a correct diagnosis.24PubMed Central. Combined biochemical profiling and DNA sequencing in the expanded newborn screening for inherited metabolic diseases
Why Early Recognition Changes Everything
The reason pediatricians emphasize checking stool color and monitoring jaundice closely in the first weeks of life is that timing matters enormously for many of these conditions. Biliary atresia outcomes are dramatically better when the Kasai procedure is performed before 60 days of age; delays of even a few weeks can shift a child from the group that achieves bile flow to the group that needs transplant. Galactosemia can cause fatal liver failure in weeks if lactose-containing feeds continue, but switching to a soy-based formula halts the damage almost immediately. GALD can be devastating in a first affected pregnancy, but once the diagnosis is known, treating the mother with immunoglobulin in subsequent pregnancies prevents most of the liver injury.
For parents, the practical takeaway is straightforward: persistent jaundice beyond two weeks of age, pale or clay-colored stools, dark urine, a firm or enlarged liver felt on examination, or poor weight gain in a jaundiced baby all warrant prompt evaluation of direct bilirubin and liver function. These signs do not always mean something serious, but when they do, catching the problem early makes an outsized difference.
When No Cause Is Found
Even with modern diagnostics, a meaningful fraction of neonatal liver disease cases never receive a definitive explanation. This is particularly true for so-called idiopathic neonatal hepatitis, a catchall label applied when a newborn has inflamed liver cells and cholestasis but no identifiable infectious, metabolic, genetic, or structural cause. As genetic testing has advanced, the idiopathic category has been shrinking: conditions that were once lumped into “unknown cause” neonatal hepatitis have turned out to be rare metabolic or genetic disorders identifiable through exome or genome sequencing. The hope is that as sequencing becomes a routine part of the diagnostic workup, fewer families will be left without answers. In the meantime, babies in this category are typically managed with supportive care, nutritional optimization, and fat-soluble vitamin supplementation while clinicians monitor whether the cholestasis resolves on its own or progresses.